Showing results (2051-2060 of 2,230) with videos related to
Sort By:
Pageof 223
Immunity|March 23, 2005
A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cellsAharon G Freud, Brian Becknell, Sameek Roychowdhury, et al.The Journal of Infectious Diseases|November 2, 2019
What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic ReviewShelly Bolotin, Stephanie L Hughes, Nazish Gul, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 10, 2025
Genetic dynamics of the Duffy antigen receptor for chemokines gene and Plasmodium vivax circulation within sub-Saharan AfricaFavour Adeloye, Kaothar O Lambe, Jennifer A Oboh, et al.Pain Medicine (Malden, Mass.)|May 11, 2020
Evidence of Neural Microstructure Abnormalities in Type I Chiari Malformation: Associations Among Fiber Tract Integrity, Pain, and Cognitive DysfunctionJames R Houston, Michelle L Hughes, Ilana J Bennett, et al.Acta Tropica|November 21, 2013
Harnessing mosquito-Wolbachia symbiosis for vector and disease controlKostas Bourtzis, Stephen L Dobson, Zhiyong Xi, et al.Veterinary and Comparative Oncology|November 5, 2019
Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B-cell lymphoma treated with a 19-week CHOP protocolAmber Wolf-Ringwall, Lynelle Lopez, Robyn Elmslie, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 7, 2023
Positron emission tomography myocardial perfusion imaging (PET MPI) findings predictive of post-liver transplant major adverse cardiac eventsDempsey L Hughes, Jason Pan, Adeline R Answine, et al.The Journal of Rheumatology|May 13, 2020
Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical TrialsStephen J Balevic, Christoph P Hornik, Thomas P Green, et al.Investigational New Drugs|March 18, 2017
Human mass balance study and metabolite profiling of 14C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancerLotte van Andel, Z Zhang, S Lu, et al.Palliative Medicine|December 8, 2022
Palliative and end-of-life care needs, experiences, and preferences of LGBTQ+ individuals with serious illness: A systematic mixed-methods reviewWilliam E Rosa, Kailey E Roberts, Debbie Braybrook, et al.Pageof 223